MILLENNIUM MANAGEMENT LLC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 86 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.18 and the average weighting 1.2%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$212,000
-54.8%
340,236
-38.8%
0.00%
-100.0%
Q3 2019$469,000
-79.7%
555,800
-83.8%
0.00%
-66.7%
Q2 2019$2,307,000
+25.7%
3,426,898
+517.7%
0.00%
+50.0%
Q3 2018$1,836,000
-76.6%
554,757
-84.0%
0.00%
-80.0%
Q2 2018$7,845,000
-47.9%
3,471,516
-33.1%
0.01%
-50.0%
Q1 2018$15,052,000
+77.6%
5,190,087
+70.9%
0.02%
+66.7%
Q4 2017$8,474,000
-4.4%
3,037,446
+25.1%
0.01%
-14.3%
Q3 2017$8,864,000
+150.6%
2,428,605
+52.4%
0.01%
+133.3%
Q2 2017$3,537,000
+19550.0%
1,593,200
+5001.3%
0.01%
Q1 2017$18,000
+38.5%
31,231
+111.0%
0.00%
Q3 2016$13,000
-23.5%
14,804
-15.1%
0.00%
Q2 2016$17,000
-69.1%
17,435
-73.2%
0.00%
Q4 2014$55,0000.0%65,126
+30.3%
0.00%
Q3 2014$55,000
-91.2%
49,995
-85.3%
0.00%
-100.0%
Q4 2013$623,000
-1.1%
340,286
+11.3%
0.00%0.0%
Q3 2013$630,000
-21.4%
305,645
-4.7%
0.00%0.0%
Q2 2013$802,000320,8270.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Greylock XI GP Limited Partnership 584,004$1,068,000100.00%
GREAT POINT PARTNERS LLC 2,325,000$4,255,0001.89%
Sarissa Capital Management LP 2,570,759$4,704,0001.60%
Deer VI & Co. LLC 675,242$1,236,0000.68%
Palo Alto Investors LP 1,200,800$2,197,0000.16%
Baupost Group 3,829,350$7,008,0000.11%
Gruss Capital Management LP 533,253$976,0000.05%
Granahan Investment Management 676,451$1,238,0000.04%
Fore Research & Management, LP 674,200$1,233,0000.04%
TFS CAPITAL LLC 210,369$385,0000.03%
View complete list of AVEO PHARMACEUTICALS INC shareholders